Exanthema - 21 Studies Found Completed : Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE) : Polymorphic Light Eruption (PLE) : 2007-05-10 : Drug: Afamelanotide (CUV1647) 16mg implant Completed : Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer : Rash : 2007-05-10 : Drug: Minocycline Patients wil Terminated : 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX : Rash : 2012-07-11 : Drug: Pimecrolimus Pimecrolimu Completed : Fluoride Varnish for Treatment of White Spot Lesions : White Spot Lesions : 2011-12-22 : Device: Vanish varnish 5% sodi Completed : Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash : Acneiform Rash : 2010-12-07 : Drug: Threolone ointment ointm Not yet recruiting : Effect of Curodont Repair on Color Change of White Spot Lesions : White Spot Lesion : 2016-09-21 : Drug: Curodont Repair composed Active, not recruiting : Effect of CO2 Laser on Enamel White Spot Lesion Formation Around Orthodontic Brackets : White Spot Lesion : 2017-04-11 : Radiation: CO2 laser irradiation Not yet recruiting : One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique : White Spot Lesions : 2016-09-20 : Drug: Vanish xt Extended Contact Varnish Completed : Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients : Tooth; Lesion, White Spot Lesions : 2011-04-01 : Drug: elmex® gelée 1 Active, not recruiting : FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema : Colorectal Cancer Metastatic : 2011-03-11 : Drug: FOLFIRI + Cetuximab <<< Previous | Next >>>
